home / stock / alim / alim quote
Last: | $3.34 |
---|---|
Change Percent: | -1.45% |
Open: | $3.49 |
Close: | $3.34 |
High: | $3.7 |
Low: | $3.325 |
Volume: | 48,043 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.34 | $3.49 | $3.34 | $3.7 | $3.325 | 48,043 | 04-19-2024 |
$3.44 | $3.55 | $3.44 | $3.6599 | $3.27 | 56,785 | 04-18-2024 |
$3.55 | $3.55 | $3.55 | $3.59 | $3.5086 | 4,391 | 04-17-2024 |
$3.58 | $3.55 | $3.58 | $3.74 | $3.53 | 49,289 | 04-16-2024 |
$3.54 | $3.47 | $3.54 | $3.65 | $3.47 | 37,270 | 04-15-2024 |
$3.52 | $3.8 | $3.52 | $3.83 | $3.475 | 56,087 | 04-12-2024 |
$3.85 | $3.76 | $3.85 | $3.91 | $3.76 | 24,446 | 04-11-2024 |
$3.75 | $3.77 | $3.75 | $3.81 | $3.63 | 79,156 | 04-10-2024 |
$3.8 | $3.84 | $3.8 | $3.84 | $3.78 | 11,219 | 04-09-2024 |
$3.78 | $3.91 | $3.78 | $3.91 | $3.76 | 35,050 | 04-08-2024 |
$3.85 | $3.89 | $3.85 | $3.975 | $3.77 | 28,939 | 04-05-2024 |
$3.9 | $3.98 | $3.9 | $3.98 | $3.86 | 140,777 | 04-04-2024 |
$3.95 | $4.01 | $3.95 | $4.01 | $3.83 | 160,103 | 04-03-2024 |
$3.95 | $3.81 | $3.95 | $3.95 | $3.71 | 58,896 | 04-02-2024 |
$3.85 | $3.9 | $3.85 | $3.97 | $3.76 | 94,652 | 04-01-2024 |
$3.9 | $3.92 | $3.9 | $4.01 | $3.76 | 57,605 | 03-29-2024 |
$3.9 | $3.92 | $3.9 | $4.01 | $3.76 | 57,605 | 03-28-2024 |
$3.9 | $3.88 | $3.9 | $3.945 | $3.78 | 41,822 | 03-27-2024 |
$3.87 | $4.01 | $3.87 | $4.02 | $3.8 | 79,437 | 03-26-2024 |
$3.99 | $4.08 | $3.99 | $4.2399 | $3.93 | 319,509 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Alimera Sciences Inc. Company Name:
ALIM Stock Symbol:
NASDAQ Market:
Alimera Sciences Inc. Website:
ATLANTA, March 20, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better...
ATLANTA, March 19, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that th...